Variant report
Variant | nsv1029366 |
---|---|
Chromosome Location | chr9:11422823-11453079 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9407479 | chr9:11422823-11422824 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs571626732 | chr9:11422828-11422829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs146709852 | chr9:11422846-11422847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs537700622 | chr9:11422903-11422904 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs9407480 | chr9:11422969-11422970 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs139136342 | chr9:11422996-11422997 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs372972971 | chr9:11423001-11423002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs372034046 | chr9:11423013-11423014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs140263378 | chr9:11423042-11423043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs536377739 | chr9:11423056-11423057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs532736101 | chr9:11423086-11423087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs538633155 | chr9:11423099-11423100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs145253187 | chr9:11423121-11423122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573341688 | chr9:11423142-11423143 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs147971783 | chr9:11423187-11423188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs557938893 | chr9:11423188-11423189 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs202106580 | chr9:11423211-11423212 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs578005998 | chr9:11423222-11423223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs140894282 | chr9:11423277-11423278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs563182508 | chr9:11423283-11423284 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs573559932 | chr9:11423330-11423331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs542390775 | chr9:11423333-11423334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs559036093 | chr9:11423346-11423347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs199642422 | chr9:11423348-11423349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs190022620 | chr9:11423363-11423364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs16927498 | chr9:11423431-11423432 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs192675339 | chr9:11423456-11423457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs987846 | chr9:11423465-11423466 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs1335465 | chr9:11423473-11423474 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs567590111 | chr9:11423474-11423475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs1335464 | chr9:11423524-11423525 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
32 | rs546989317 | chr9:11423641-11423642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs185318220 | chr9:11423652-11423653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs539095322 | chr9:11423663-11423664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs200655352 | chr9:11423664-11423665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs116271640 | chr9:11423676-11423677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs571416823 | chr9:11423682-11423683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs188751004 | chr9:11423689-11423690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs150173985 | chr9:11423709-11423710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs575880119 | chr9:11423714-11423715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs369620632 | chr9:11423739-11423740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs543275481 | chr9:11423743-11423744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs181950966 | chr9:11423753-11423754 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs551860674 | chr9:11423762-11423763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs552503215 | chr9:11423763-11423764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs138634963 | chr9:11423770-11423771 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs76286380 | chr9:11423785-11423786 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs2152267 | chr9:11423810-11423811 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs72698171 | chr9:11423824-11423825 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs7864970 | chr9:11423835-11423836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Glioma | 20126413 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:11417800-11425800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr9:11425800-11426000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr9:11426200-11426600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr9:11426600-11431800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr9:11427600-11428800 | Enhancers | Fetal Heart | heart |
6 | chr9:11428800-11429200 | Weak transcription | Fetal Heart | heart |
7 | chr9:11429200-11429400 | Enhancers | Fetal Heart | heart |
8 | chr9:11429400-11432400 | Weak transcription | Fetal Heart | heart |
9 | chr9:11431400-11431800 | Enhancers | Fetal Brain Male | brain |
10 | chr9:11431600-11431800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
11 | chr9:11431800-11432400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr9:11432200-11432600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
13 | chr9:11432400-11434200 | Enhancers | Fetal Heart | heart |
14 | chr9:11433400-11433800 | Active TSS | Right Atrium | heart |
15 | chr9:11434200-11434600 | Weak transcription | Fetal Heart | heart |
16 | chr9:11434600-11435600 | Enhancers | Fetal Heart | heart |
17 | chr9:11447600-11448400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
18 | chr9:11451600-11451800 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
19 | chr9:11452000-11452400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |